Sagimet Biosciences Inc. (SGMT) ROE
- 2026-06-30: ROE -18.38%.
- 2026-03-31: ROE -42.47%.
- 2025-12-31: ROE -45.82%.
- 2025-09-30: ROE -48.36%.
Complete source-backed roe history.
- Available history
- 2022-12-31 to 2026-06-30
- Data captured
Historical ROE
| Date | ROE |
|---|---|
| 2026-06-30 | -18.38% |
| 2026-03-31 | -42.47% |
| 2025-12-31 | -45.82% |
| 2025-09-30 | -48.36% |
| 2025-06-30 | -45.62% |
| 2025-03-31 | -41.09% |
| 2024-12-31 | -29.25% |
| 2024-09-30 | -21.98% |
| 2024-06-30 | -15.96% |
| 2024-03-31 | -14.69% |
| 2023-12-31 | -30.61% |
| 2023-09-30 | -27.50% |
| 2023-06-30 | 14.13% |
| 2023-03-31 | 14.71% |
| 2022-12-31 | 16.31% |
Annual ROE
| Date | ROE |
|---|---|
| 2025-12-31 | -45.82% |
| 2024-12-31 | -29.25% |
| 2023-12-31 | -30.61% |
| 2022-12-31 | 16.31% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |